Search
for

    Learn

    0 / 0 results
    — no results

    Research

    5 / 1000+ results

      research Overtreatment of Transient Maternal Hyperthyroidism Resulting in Fetal Goiter

      1 citations, August 2021 in “NeoReviews”
      A 25-year-old pregnant woman treated for hyperthyroidism with propylthiouracil (PTU) developed a fetal goiter, detected at 33 weeks of gestation. Discontinuation of PTU led to a reduction in the goiter size without causing airway obstruction. The baby, delivered at 39 weeks by cesarean section, had normal thyroid function and no respiratory distress. This case underscored the need to distinguish between transient gestational hyperthyroidism and true hyperthyroidism to prevent overtreatment and complications like fetal goiter, emphasizing the importance of a multidisciplinary approach for optimal outcomes.
      Endocrine Disorders and Infertility

      research Endocrine Disorders and Infertility

      1 citations, March 2011 in “Infertility”
      Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.
      Endocrinology

      research Endocrinology

      April 2023 in “Clinical Chemistry and Laboratory Medicine”
      The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

    Community Join

    1 / 1 results

      community Verteporfin and Microneedling

      in Treatments 3 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.